Global Genomics Market, By Deliverables (Product and Services), Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification), Process (Sequencing, Library Preparation, Data Analysis), Application ( Epigenomics, Functional, Biomarker Discovery, Pathway Analysis), End-User(Government and Academic Institutes, Clinical Research, Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
The genomics market is expected to witness market growth at a rate of 17.75% in the forecast period of 2021 to 2028. Data Bridge Market Research report on genomics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The expansion of healthcare sector globally is escalating the growth of genomics market.
Genomics refers to the study of genomes and their communication with different stimuli, which is focus of development activities. Genomics is considered one of the reasons behind the rise in technologies providing a better apprehension of genomes and a better understanding of interaction of genomics.
The rise in the government funding to support genomics projects across the globe acts as one of the major factors driving the growth of genomics market. The surge in incidence of cancer and increasing applications of next-generation sequencing in cancer research, and advent of genetic susceptibility and severity to SARS-CoV-2 infection by combining research efforts using existing genetic databases accelerate the market growth. The use of multiomic-based approaches and genome-wide association studies (GWAS) for discovering biological networks and common variants underlying host-pathogen interactions, and utilization of genomics for even deciphering COVID-19 complications, resistance, and susceptibility further influence the market. Additionally, development in healthcare infrastructure, increase in healthcare spending and surge in government funding to support genomics projects, positively affects the genomics market. Furthermore, use of genomics in specialized/personalized medicine extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the genomic equipment and lack of trained professionals are expected to obstruct the market growth. Issues in securing storage of large volumes of sequenced data are projected to challenge the genomics market in the forecast period of 2021-2028.
This genomics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on genomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Genomics Market Scope and Market Size
The genomics market is segmented on the basis of deliverables, technology, process, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of Deliverables, the genomics market is segmented into Product and Services. Product is further segmented into Reagents and Instruments. Services are further segmented into Core Genomics, NGS-Based, Biomarker Translation, Computational and Others.
- On the basis of technology, the genomics market is segmented into sequencing, microarray, PCR, nucleic acid extraction and purification.
- On the basis of process, the genomics market is segmented into sequencing, library preparation, and data analysis.
- On the basis of Application, the genomics market is segmented into epigenomics, functional, biomarker discovery, and pathway analysis. Epigenomics are further segmented into chromatin immunoprecipitation, bisulfite sequencing, methylated DNA immunoprecipitation, chromatin accessibility assays, high-resolution melt and microarray analysis. Functional is further segmented into real-time PCR, transfection, RNA interference, SNP analysis and mutational analysis. Biomarker discovery is further segmented into real-time PCR, mass spectrometry, microarray analysis, bioinformatics, statistical analysis and DNA sequencing. Pathway analysis is further segmented into microarray analysis, bead-based analysis, real-time PCR, proteomics tools and others.
- On the basis of end-user, the genomics market is segmented into government and academic institutes, clinical research, biotechnology and pharmaceutical companies, hospitals and clinics, and others.
Global Genomics Market Country Level Analysis
The genomics market is analysed and market size insights and trends are provided by country, deliverables, technology, process, application, and end-user as referenced above.
The countries covered in the genomics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the genomics market because of the increase in the number of research programs, and high number of strategic partnerships within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the increasing adoption of genomic technologies owing to the initiation of various research programs in the region.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The genomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for genomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the genomics market. The data is available for historic period 2010-2019.
Competitive Landscape and Genomics Market Share Analysis
The genomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to genomics market.
The major players covered in the genomics market report are General Electric, Danaher, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Qiagen, Merck & Co., Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Genotypic Technology Pvt Ltd, Macrogen, Inc., Eurofins Genomics LLC, PerkinElmer Inc., Personalis Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies., Eppendorf AG, Novogene Corporation, SciGenom Labs Pvt. Ltd, Takara Holdingd Inc., Kohlberg Kravis Roberts & Co. L.P., Dnastar and New England Biolabs, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Genomics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.